Earnings calendar/PHAT
Phathom Pharmaceuticals, Inc. (PHAT)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$0.07
Street estimate
Revenue target
$85.4M
Street estimate
Trailing EPS (avg 4Q)
$-0.22
Beat rate last 4: 50%
Latest EPS YoY
+73.4%
vs 2025-08-07
Latest revenue YoY
+88.0%
How results look so far
Trailing revenue (avg 4Q)
$59.9M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 30, 2026
EPS miss
EPS actual / est
$-0.21 / $-0.18
-19.6%
Revenue actual / est
$74.3M / $73.2M
+1.4%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $0.07 | Pending | — | $85.4M | Pending | — |
| 7/30/2026 | $-0.18 | $-0.21 | -19.6% | $73.2M | $74.3M | +1.4% |
| 5/7/2026upcoming | $-0.17 | Pending | — | $58.8M | Pending | — |
| 4/30/2026 | $-0.27 | $-0.37 | -37.0% | $55.9M | $58.3M | +4.3% |
| 3/5/2026upcoming | $-0.10 | Pending | — | — | Pending | — |
| 2/26/2026 | $-0.32 | $-0.16 | +49.9% | $57.2M | $57.6M | +0.7% |
| 10/30/2025 | $-0.30 | $-0.15 | +50.0% | $57.4M | $49.5M | -13.8% |
| 8/7/2025 | $-0.76 | $-0.79 | -3.9% | $46.8M | $39.5M | -15.5% |
| 5/1/2025 | $-1.06 | $-1.07 | -0.9% | $35.6M | $28.5M | -20.0% |
| 3/6/2025 | $-1.29 | $-0.79 | +38.8% | $29.0M | $29.7M | +2.2% |
| 11/7/2024 | $-1.57 | $-1.32 | +15.9% | $25.8M | $16.4M | -36.5% |
| 8/8/2024 | $-1.20 | $-1.25 | -4.2% | $5.8M | $7.3M | +26.1% |
| 5/9/2024 | $-1.43 | $-1.42 | +0.7% | $2.0M | $1.9M | -6.7% |
| 3/7/2024 | $-0.92 | $-0.80 | +13.0% | $410,000 | $682,000 | +66.3% |
| 11/9/2023 | $-0.95 | $-0.76 | +20.0% | $800,000 | Pending | — |
| 8/10/2023 | $-0.95 | $-0.84 | +11.6% | — | Pending | — |
| 5/10/2023 | $-1.34 | $-0.89 | +33.6% | — | Pending | — |
| 2/28/2023 | $-1.50 | $-1.33 | +11.3% | $200,000 | Pending | — |
| 11/8/2022 | $-1.32 | $-1.32 | 0.0% | — | Pending | — |
| 8/2/2022 | $-1.03 | $-1.33 | -29.1% | — | Pending | — |
| 5/10/2022 | $-0.97 | $-1.07 | -10.3% | $211,000 | Pending | — |
| 3/1/2022 | $-0.86 | $-0.95 | -10.5% | — | Pending | — |
| 11/8/2021 | $-0.78 | $-0.98 | -25.6% | — | Pending | — |
| 8/10/2021 | $-1.07 | $-1.00 | +6.5% | — | Pending | — |
| 5/11/2021 | $-1.11 | $-0.96 | +13.5% | — | Pending | — |
| 3/30/2021 | $-0.93 | $-1.58 | -69.9% | — | Pending | — |
| 11/10/2020 | $-0.68 | $-1.02 | -50.0% | — | Pending | — |
| 8/6/2020 | $-0.56 | $-0.64 | -14.3% | — | Pending | — |
| 5/12/2020 | $-0.59 | $-0.62 | -5.1% | — | Pending | — |
| 3/19/2020 | $-1.25 | $-3.97 | -217.6% | — | Pending | — |
| 11/25/2019 | $-1.14 | $-9.30 | -715.8% | — | Pending | — |
| 10/28/2019 | — | $-10.23 | — | — | Pending | — |
| 3/31/2019 | — | $-0.15 | — | — | Pending | — |
| 12/31/2018 | — | $-0.06 | — | — | Pending | — |
| 9/30/2018 | — | $-0.03 | — | — | Pending | — |
| 6/30/2018 | — | $-0.05 | — | — | Pending | — |
| 3/31/2018 | — | $-0.05 | — | — | Pending | — |
Need PHAT data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.